Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophia Heydari
Observed name:
Heydari, Sophia
Institution:
Zanjan University of Medical Sciences
Observed institution:
Zanjan University of Medical Sciences
ORCID:
0000-0003-2807-2391
Observed ORCID:
0000-0003-2807-2391
OpenAlex ID:
A5061367041
MiR-21 and Tocilizumab interactions improve COVID-19 myocarditis outcomes
2023
·
Amir Hossein Heydari
, Saeid Ghaffari
, et al.
·
Therapeutic Advances in Cardiovascular Disease
·
12
PDF
Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2
2022
·
Amir Hossein Heydari
, Mojtaba Fathi
, et al.
·
Cardiovascular Therapeutics
·
8
PDF
Satralizumab, Novel Interleukine-6 Inhibitor for Preventing Descending Thoracic Aorta Aneurysm Development
2021
·
Amir Hossein Heydari
, Sophia Heydari
, et al.
·
Cardiovascular Drugs and Therapy
·
2
Show more works
View as search
Works count:
5
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type